Page last updated: 2024-10-17

citric acid, anhydrous and Thrombosis

citric acid, anhydrous has been researched along with Thrombosis in 40 studies

Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.

Thrombosis: Formation and development of a thrombus or blood clot in the blood vessel.

Research Excerpts

ExcerptRelevanceReference
" Current drug-eluting stents release non-selective anti-proliferative drugs such as paclitaxel from the stent surface that not only inhibit growth of smooth muscle cells but also delay endothelial healing, potentially leading to stent thrombosis."4.02Candidates for smart cardiovascular medical device coatings: A comparative study with endothelial and smooth muscle cells. ( Ceresnakova, M; Hudson, SP; Murray, D; Soulimane, T, 2021)
"Hypocalcemia was common but remained mild and asymptomatic."2.82Inpatient citrate-based hemodialysis in pediatric patients. ( Cutler, D; Fajardo, C; Sahney, S; Sanchez, CP; Sheth, R, 2016)
"During this small short term study citrate dialysis fluid was apparently safe to use in HD and on-line HDF treatments."2.78Replacement of acetate with citrate in dialysis fluid: a randomized clinical trial of short term safety and fluid biocompatibility. ( Alquist, M; Christensson, A; Grundström, G; Nilsson, LG; Segelmark, M, 2013)
"Thirty end-stage renal disease (ESRD) patients with subclavian or jugular single lumen catheters as temporary vascular access for hemodialysis were enrolled."2.69Filling hemodialysis catheters in the interdialytic period: heparin versus citrate versus polygeline: a prospective randomized study. ( Boh, M; Buturović, J; Ivanovich, P; Kandus, A; Klinkmann, J; Ponikvar, R, 1998)
"Mice of acute pulmonary thromboembolism, and rats of arterial thrombosis were used to determine the anti-thrombotic effect of the formula."1.40Anti-thrombotic effect of a novel formula from Corni fructus with malic acid, succinic acid and citric acid. ( Bian, HM; Zhang, QC; Zhao, Y, 2014)
"There were 22 line infections and in approximately 70% of cases the infection was associated with a reduction in platelet count."1.34Cryosupernatant and solvent detergent fresh-frozen plasma (Octaplas) usage at a single centre in acute thrombotic thrombocytopenic purpura. ( Berryman, J; Flynn, M; Longair, I; Machin, SJ; Scully, M, 2007)
" Citrate anticoagulation during single-needle hemodialysis, according to our protocol, is safe and effective."1.33Citrate anticoagulation for single-needle hemodialysis: safety and efficacy. ( Buturović-Ponikvar, J; Gubensek, J; Ponikvar, R, 2005)

Research

Studies (40)

TimeframeStudies, this research(%)All Research%
pre-19907 (17.50)18.7374
1990's3 (7.50)18.2507
2000's4 (10.00)29.6817
2010's19 (47.50)24.3611
2020's7 (17.50)2.80

Authors

AuthorsStudies
Ceresnakova, M1
Murray, D1
Soulimane, T1
Hudson, SP1
Li, Y5
Li, YC1
Liu, XT1
Zhang, L5
Chen, YH1
Zhao, Q1
Gao, W1
Liu, B1
Yang, H1
Li, P1
Trakarnvanich, T1
Sirivongrangson, P1
Trongtrakul, K1
Srisawat, N1
Schriner, JB1
Mankame, A1
Olson, SD1
Cox, CS1
Gill, BS1
Liu, J5
Liu, Z4
Zhao, T1
Su, T1
Jin, Q1
Poh, CB1
Tan, PC1
Kam, JW1
Siau, C1
Lim, NL1
Yeon, W1
Cui, HH1
Ding, HT1
Song, XY1
Yan, P1
Chea, KL1
Liu, JS1
Chionh, CY1
Halim, AA1
Alsayed, B1
Embarak, S1
Yaseen, T1
Dabbous, S1
Fontaine, O1
Dueluzeau, R1
Raibaud, P1
Chabanet, C1
Popoff, MR1
Badoual, J1
Gabilan, JC1
Andremont, A1
Gómez, L1
Andrés, S1
Sánchez, J1
Alonso, JM1
Rey, J1
López, F1
Jiménez, A1
Yan, Z1
Zhou, L1
Zhao, Y5
Wang, J6
Huang, L2
Hu, K1
Liu, H4
Wang, H3
Guo, Z1
Song, Y1
Huang, H4
Yang, R1
Owen, TW1
Al-Kaysi, RO1
Bardeen, CJ1
Cheng, Q1
Wu, S1
Cheng, T1
Zhou, X1
Wang, B4
Zhang, Q4
Wu, X2
Yao, Y3
Ochiai, T1
Ishiguro, H2
Nakano, R2
Kubota, Y2
Hara, M1
Sunada, K1
Hashimoto, K1
Kajioka, J1
Fujishima, A1
Jiao, J3
Gai, QY3
Wang, W2
Zang, YP2
Niu, LL2
Fu, YJ3
Wang, X4
Yao, LP1
Qin, QP1
Wang, ZY1
Aleksic Sabo, V1
Knezevic, P1
Borges-Argáez, R1
Chan-Balan, R1
Cetina-Montejo, L1
Ayora-Talavera, G1
Sansores-Peraza, P1
Gómez-Carballo, J1
Cáceres-Farfán, M1
Jang, J1
Akin, D1
Bashir, R1
Yu, Z1
Zhu, J2
Jiang, H1
He, C2
Xiao, Z1
Xu, J2
Sun, Q1
Han, D1
Lei, H1
Zhao, K2
Zhu, L1
Li, X4
Fu, H2
Wilson, BK1
Step, DL1
Maxwell, CL1
Gifford, CA1
Richards, CJ1
Krehbiel, CR1
Warner, JM1
Doerr, AJ1
Erickson, GE1
Guretzky, JA1
Rasby, RJ1
Watson, AK1
Klopfenstein, TJ1
Sun, Y4
Pham, TD1
Lee, BK1
Yang, FC1
Wu, KH1
Lin, WP1
Hu, MK1
Lin, L3
Shao, J1
Sun, M1
Xu, G1
Zhang, X6
Xu, N1
Wang, R1
Liu, S1
He, H1
Dong, X2
Yang, M2
Yang, Q1
Duan, S1
Yu, Y2
Han, J2
Zhang, C3
Chen, L2
Yang, X1
Li, W3
Wang, T2
Campbell, DA1
Gao, K1
Zager, RA1
Johnson, ACM1
Guillem, A1
Keyser, J1
Singh, B1
Steubl, D1
Schneider, MP1
Meiselbach, H1
Nadal, J1
Schmid, MC1
Saritas, T1
Krane, V1
Sommerer, C1
Baid-Agrawal, S1
Voelkl, J1
Kotsis, F1
Köttgen, A1
Eckardt, KU1
Scherberich, JE1
Li, H4
Yao, L2
Sun, L3
Zhu, Z1
Naren, N1
Zhang, XX2
Gentile, GL1
Rupert, AS1
Carrasco, LI1
Garcia, EM1
Kumar, NG1
Walsh, SW1
Jefferson, KK1
Guest, RL1
Samé Guerra, D1
Wissler, M1
Grimm, J1
Silhavy, TJ1
Lee, JH2
Yoo, JS1
Kim, Y1
Kim, JS2
Lee, EJ1
Roe, JH1
Delorme, M1
Bouchard, PA1
Simon, M1
Simard, S1
Lellouche, F1
D'Urzo, KA1
Mok, F1
D'Urzo, AD1
Koneru, B1
Lopez, G1
Farooqi, A1
Conkrite, KL1
Nguyen, TH1
Macha, SJ1
Modi, A1
Rokita, JL1
Urias, E1
Hindle, A1
Davidson, H1
Mccoy, K1
Nance, J1
Yazdani, V1
Irwin, MS1
Yang, S1
Wheeler, DA1
Maris, JM1
Diskin, SJ1
Reynolds, CP1
Abhilash, L1
Kalliyil, A1
Sheeba, V1
Hartley, AM2
Meunier, B2
Pinotsis, N1
Maréchal, A2
Xu, JY1
Genko, N1
Haraux, F1
Rich, PR1
Kamalanathan, M1
Doyle, SM1
Xu, C1
Achberger, AM1
Wade, TL1
Schwehr, K1
Santschi, PH1
Sylvan, JB1
Quigg, A1
Leong, W1
Xu, W2
Gao, S1
Zhai, X1
Wang, C2
Gilson, E1
Ye, J1
Lu, Y1
Yan, R1
Zhang, Y6
Hu, Z1
You, Q1
Cai, Q1
Yang, D1
Gu, S1
Dai, H1
Zhao, X1
Gui, C1
Gui, J1
Wu, PK1
Hong, SK1
Starenki, D1
Oshima, K1
Shao, H1
Gestwicki, JE1
Tsai, S1
Park, JI1
Wang, Y7
Zhao, R1
Gu, Z1
Dong, C2
Guo, G1
Li, L4
Barrett, HE1
Meester, EJ1
van Gaalen, K1
van der Heiden, K1
Krenning, BJ1
Beekman, FJ1
de Blois, E1
de Swart, J1
Verhagen, HJ1
Maina, T1
Nock, BA1
Norenberg, JP1
de Jong, M1
Gijsen, FJH1
Bernsen, MR1
Martínez-Milla, J1
Galán-Arriola, C1
Carnero, M1
Cobiella, J1
Pérez-Camargo, D1
Bautista-Hernández, V1
Rigol, M1
Solanes, N1
Villena-Gutierrez, R1
Lobo, M1
Mateo, J1
Vilchez-Tschischke, JP1
Salinas, B1
Cussó, L1
López, GJ1
Fuster, V1
Desco, M1
Sanchez-González, J1
Ibanez, B1
van den Berg, P1
Schweitzer, DH1
van Haard, PMM1
Geusens, PP1
van den Bergh, JP1
Zhu, X1
Huang, X2
Xu, H2
Yang, G2
Lin, Z1
Salem, HF1
Nafady, MM1
Kharshoum, RM1
Abd El-Ghafar, OA1
Farouk, HO1
Domiciano, D1
Nery, FC1
de Carvalho, PA1
Prudente, DO1
de Souza, LB1
Chalfun-Júnior, A1
Paiva, R1
Marchiori, PER1
Lu, M2
An, Z1
Jiang, J2
Li, J7
Du, S1
Zhou, H1
Cui, J1
Wu, W1
Liu, Y7
Song, J1
Lian, Q1
Uddin Ahmad, Z1
Gang, DD1
Konggidinata, MI1
Gallo, AA1
Zappi, ME1
Yang, TWW1
Johari, Y1
Burton, PR1
Earnest, A1
Shaw, K1
Hare, JL1
Brown, WA1
Kim, GA1
Han, S1
Choi, GH1
Choi, J1
Lim, YS1
Gallo, A1
Cancelli, C1
Ceron, E1
Covino, M1
Capoluongo, E1
Pocino, K1
Ianiro, G1
Cammarota, G1
Gasbarrini, A1
Montalto, M1
Somasundar, Y1
Lu, IC1
Mills, MR1
Qian, LY1
Olivares, X1
Ryabov, AD1
Collins, TJ1
Zhao, L1
Doddipatla, S1
Thomas, AM1
Nikolayev, AA1
Galimova, GR1
Azyazov, VN1
Mebel, AM1
Kaiser, RI1
Guo, S1
Yang, P1
Yu, X2
Wu, Y2
Zhang, H1
Yu, B2
Han, B1
George, MW1
Moor, MB1
Bonny, O1
Langenberg, E1
Paik, H1
Smith, EH1
Nair, HP1
Hanke, I1
Ganschow, S1
Catalan, G1
Domingo, N1
Schlom, DG1
Assefa, MK1
Wu, G2
Hayton, TW1
Becker, B1
Enikeev, D1
Netsch, C1
Gross, AJ1
Laukhtina, E1
Glybochko, P1
Rapoport, L1
Herrmann, TRW1
Taratkin, M1
Dai, W1
Shi, J2
Carreno, J1
Kloner, RA1
Pickersgill, NA1
Vetter, JM1
Kim, EH1
Cope, SJ1
Du, K1
Venkatesh, R1
Giardina, JD1
Saad, NES1
Bhayani, SB1
Figenshau, RS1
Eriksson, J1
Landfeldt, E1
Ireland, S1
Jackson, C1
Wyatt, E1
Gaudig, M1
Stancill, JS1
Happ, JT1
Broniowska, KA1
Hogg, N1
Corbett, JA1
Tang, LF1
Bi, YL1
Fan, Y2
Sun, YB1
Wang, AL1
Xiao, BH1
Wang, LF1
Qiu, SW1
Guo, SW1
Wáng, YXJ1
Sun, J2
Chu, S1
Pan, Q1
Li, D2
Zheng, S2
Ma, L1
Wang, L3
Hu, T1
Wang, F1
Han, Z1
Yin, Z1
Ge, X1
Xie, K1
Lei, P1
Dias-Santagata, D1
Lennerz, JK1
Sadow, PM1
Frazier, RP1
Govinda Raju, S1
Henry, D1
Chung, T1
Kherani, J1
Rothenberg, SM1
Wirth, LJ1
Marti, CN1
Choi, NG1
Bae, SJ1
Ni, L1
Luo, X1
Dai, T1
Yang, Y4
Lee, R1
Fleischer, AS1
Wemhoff, AP1
Ford, CR1
Kleppinger, EL1
Helms, K1
Bush, AA1
Luna-Abanto, J1
García Ruiz, L1
Laura Martinez, J1
Álvarez Larraondo, M1
Villoslada Terrones, V1
Dukic, L1
Maric, N1
Simundic, AM1
Chogtu, B1
Ommurugan, B1
Thomson, SR1
Kalthur, SG1
Benidir, M1
El Massoudi, S1
El Ghadraoui, L1
Lazraq, A1
Benjelloun, M1
Errachidi, F1
Cassar, M1
Law, AD1
Chow, ES1
Giebultowicz, JM1
Kretzschmar, D1
Salonurmi, T1
Nabil, H1
Ronkainen, J1
Hyötyläinen, T1
Hautajärvi, H1
Savolainen, MJ1
Tolonen, A1
Orešič, M1
Känsäkoski, P1
Rysä, J1
Hakkola, J1
Hukkanen, J1
Zhu, N1
Du, Q1
Hao, P1
Cao, X1
Li, CX1
Zhao, S1
Luo, XM1
Feng, JX1
Gonzalez-Cotto, M1
Guo, L1
Karwan, M1
Sen, SK1
Barb, J1
Collado, CJ1
Elloumi, F1
Palmieri, EM1
Boelte, K1
Kolodgie, FD1
Finn, AV1
Biesecker, LG1
McVicar, DW1
Qu, F1
Deng, Z1
Xie, Y2
Tang, J3
Chen, Z2
Luo, W1
Xiong, D1
Zhao, D1
Fang, J1
Zhou, Z1
Niu, PP1
Song, B1
Xu, YM1
Zhang, Z2
Qiu, N1
Yin, J1
Zhang, J3
Guo, W1
Liu, M2
Liu, T2
Chen, D5
Luo, K1
He, Z2
Zheng, G1
Xu, F1
Sun, W1
Yin, F1
van Hest, JCM1
Du, L2
Shi, X1
Kang, S1
Duan, W1
Zhang, S2
Feng, J2
Qi, N1
Shen, G1
Ren, H1
Shang, Q1
Zhao, W2
Yang, Z2
Jiang, X2
Alame, M1
Cornillot, E1
Cacheux, V1
Tosato, G1
Four, M1
De Oliveira, L1
Gofflot, S1
Delvenne, P1
Turtoi, E1
Cabello-Aguilar, S1
Nishiyama, M1
Turtoi, A1
Costes-Martineau, V1
Colinge, J1
Guo, Q1
Quan, M1
Dong, J1
Bai, J1
Han, R1
Cai, Y1
Lv, YQ1
Chen, Q1
Lyu, HD1
Deng, L1
Zhou, D1
Xiao, X1
De Langhe, S1
Billadeau, DD1
Lou, Z1
Zhang, JS1
Xue, Z1
Shen, XD1
Gao, F1
Busuttil, RW1
Kupiec-Weglinski, JW1
Ji, H1
Otano, I1
Alvarez, M1
Minute, L1
Ochoa, MC1
Migueliz, I1
Molina, C1
Azpilikueta, A1
de Andrea, CE1
Etxeberria, I1
Sanmamed, MF1
Teijeira, Á1
Berraondo, P1
Melero, I1
Zhong, Z1
Xie, X1
Yu, Q1
Zhou, C1
Liu, C2
Liu, W1
Chen, W1
Yin, Y1
Li, CW1
Hsu, JL1
Zhou, Q1
Hu, B1
Fu, P2
Atyah, M1
Ma, Q2
Xu, Y1
Dong, Q1
Hung, MC1
Ren, N1
Huang, P1
Liao, R1
Chen, X3
Cao, Q1
Yuan, X1
Nie, W1
Yang, J3
Shao, B1
Ma, X1
Bi, Z1
Liang, X1
Tie, Y1
Mo, F1
Xie, D1
Wei, Y1
Wei, X2
Dokla, EME1
Fang, CS1
Chu, PC1
Chang, CS1
Abouzid, KAM1
Chen, CS1
Blaszczyk, R1
Brzezinska, J1
Dymek, B1
Stanczak, PS1
Mazurkiewicz, M1
Olczak, J1
Nowicka, J1
Dzwonek, K1
Zagozdzon, A1
Golab, J1
Golebiowski, A1
Xin, Z1
Himmelbauer, MK1
Jones, JH1
Enyedy, I1
Gilfillan, R1
Hesson, T1
King, K1
Marcotte, DJ1
Murugan, P1
Santoro, JC1
Gonzalez-Lopez de Turiso, F1
Pedron, J1
Boudot, C1
Brossas, JY1
Pinault, E1
Bourgeade-Delmas, S1
Sournia-Saquet, A1
Boutet-Robinet, E1
Destere, A1
Tronnet, A1
Bergé, J1
Bonduelle, C1
Deraeve, C1
Pratviel, G1
Stigliani, JL1
Paris, L1
Mazier, D1
Corvaisier, S1
Since, M1
Malzert-Fréon, A1
Wyllie, S1
Milne, R1
Fairlamb, AH1
Valentin, A1
Courtioux, B1
Verhaeghe, P1
Fang, X1
Gao, M1
Gao, H1
Bi, W1
Tang, H1
Cui, Y1
Fan, H1
Yu, H1
Mathison, CJN1
Chianelli, D1
Rucker, PV1
Nelson, J1
Roland, J1
Huang, Z2
Xie, YF1
Epple, R1
Bursulaya, B1
Lee, C1
Gao, MY1
Shaffer, J1
Briones, S1
Sarkisova, Y1
Galkin, A1
Li, N1
Li, C2
Hua, S1
Kasibhatla, S1
Kinyamu-Akunda, J1
Kikkawa, R1
Molteni, V1
Tellew, JE1
Jin, X1
Pang, B1
Liu, Q2
Liu, X3
Huang, Y2
Josephine Fauci, A1
Ma, Y1
Soo Lee, M1
Yuan, W1
Gao, R1
Qi, H1
Zheng, W1
Yang, F2
Chua, H1
Wang, K1
Ou, Y1
Huang, M1
Zhu, Y1
Yu, J1
Tian, J1
Zhao, M1
Hu, J1
Yao, C1
Zhang, B1
Usawachintachit, M1
Tzou, DT1
Washington, SL1
Hu, W1
Chi, T1
Sorensen, MD1
Bailey, MR1
Hsi, RS1
Cunitz, BW1
Simon, J1
Wang, YN1
Dunmire, BL1
Paun, M1
Starr, F1
Lu, W1
Evan, AP1
Harper, JD1
Han, G1
Rodrigues, AE1
Fouladvand, F1
Falahi, E1
Asbaghi, O1
Abbasnezhad, A1
Anigboro, AA1
Avwioroko, OJ1
Cholu, CO1
Sonei, A1
Fazelipour, S1
Kanaani, L1
Jahromy, MH1
Jo, K1
Hong, KB1
Suh, HJ1
Park, JH1
Shin, E1
Park, E1
Kouakou-Kouamé, CA1
N'guessan, FK1
Montet, D1
Djè, MK1
Kim, GD1
González-Fernández, D1
Pons, EDC1
Rueda, D1
Sinisterra, OT1
Murillo, E1
Scott, ME1
Koski, KG1
Shete, PB1
Gonzales, R1
Ackerman, S1
Cattamanchi, A1
Handley, MA1
Li, XX1
Xiao, SZ1
Gu, FF1
He, WP1
Ni, YX1
Han, LZ1
Heffernan, JK1
Valgepea, K1
de Souza Pinto Lemgruber, R1
Casini, I1
Plan, M1
Tappel, R1
Simpson, SD1
Köpke, M1
Nielsen, LK1
Marcellin, E1
Cen, YK1
Lin, JG1
Wang, YL1
Wang, JY1
Liu, ZQ1
Zheng, YG1
Spirk, D1
Noll, S1
Burnier, M1
Rimoldi, S1
Noll, G1
Sudano, I1
Penzhorn, BL1
Oosthuizen, MC1
Kobos, LM1
Alqatani, S1
Ferreira, CR1
Aryal, UK1
Hedrick, V1
Sobreira, TJP1
Shannahan, JH1
Gale, P1
Singhroy, DN1
MacLean, E1
Kohli, M1
Lessem, E1
Branigan, D1
England, K1
Suleiman, K1
Drain, PK1
Ruhwald, M1
Schumacher, S1
Denkinger, CM1
Waning, B1
Van Gemert, W1
Pai, M1
Myers, RK1
Bonsu, JM1
Carey, ME1
Yerys, BE1
Mollen, CJ1
Curry, AE1
Douglas, TA1
Alinezhadbalalami, N1
Balani, N1
Schmelz, EM1
Davalos, RV1
Kamaldinov, T1
Erndt-Marino, J1
Levin, M1
Kaplan, DL1
Hahn, MS1
Heidarimoghadam, R1
Farmany, A1
Lee, JJ1
Kang, J1
Park, S1
Cho, JH1
Oh, S1
Park, DJ1
Perez-Maldonado, R1
Cho, JY1
Park, IH1
Kim, HB1
Song, M1
Mfarrej, B1
Jofra, T1
Morsiani, C1
Gagliani, N1
Fousteri, G1
Battaglia, M1
Giuliano, C1
Levinger, I1
Vogrin, S1
Neil, CJ1
Allen, JD1
Lv, Y1
Yuan, R1
Cai, B1
Bahrami, B1
Chowdhury, AH1
Yang, C2
Qiao, Q1
Liu, SF1
Zhang, WH1
Kolano, L1
Knappe, D1
Volke, D1
Sträter, N1
Hoffmann, R1
Coussens, M1
Calders, P1
Lapauw, B1
Celie, B1
Banica, T1
De Wandele, I1
Pacey, V1
Malfait, F1
Rombaut, L1
Vieira, D1
Angel, S1
Honjol, Y1
Gruenheid, S1
Gbureck, U1
Harvey, E1
Merle, G1
Seo, G1
Lee, G1
Kim, MJ1
Baek, SH1
Choi, M1
Ku, KB1
Lee, CS1
Jun, S1
Park, D1
Kim, HG1
Kim, SJ1
Lee, JO1
Kim, BT1
Park, EC1
Kim, SI1
Ende, M1
Kirkkala, T1
Loitzenbauer, M1
Talla, D1
Wildner, M1
Miletich, R1
Criado, A1
Lavela, P1
Tirado, JL1
Pérez-Vicente, C1
Kang, D1
Feng, D2
Fang, Z1
Wei, F1
De Clercq, E1
Pannecouque, C1
Zhan, P1
Guo, Y1
Shen, Y1
Wang, Q2
Kawazoe, Y1
Jena, P1
Sun, Z1
Li, Z3
Liang, H1
Xu, X1
Ma, G1
Huo, X1
Church, JS1
Chace-Donahue, F1
Blum, JL1
Ratner, JR1
Zelikoff, JT1
Schwartzer, JJ1
Fiseha, T1
Tamir, Z1
Yao, W1
Wang, P1
Mi, K1
Cheng, J1
Gu, C1
Huang, J2
Sun, HB1
Xing, WQ1
Liu, XB1
Zheng, Y1
Yang, SJ1
Wang, ZF1
Liu, SL1
Ba, YF1
Zhang, RX1
Liu, BX1
Fan, CC1
Chen, PN1
Liang, GH1
Yu, YK1
Wang, HR1
Li, HM1
Li, ZX1
Lalani, SS1
Anasir, MI1
Poh, CL1
Khan, IT1
Nadeem, M1
Imran, M1
Khalique, A1
Raspini, B1
Porri, D1
De Giuseppe, R1
Chieppa, M1
Liso, M1
Cerbo, RM1
Civardi, E1
Garofoli, F1
Monti, MC1
Vacca, M1
De Angelis, M1
Cena, H1
Kong, D1
Han, X1
Zhou, Y3
Xue, H1
Zhang, W1
Ruan, Z1
Li, S2
Noer, PR1
Kjaer-Sorensen, K1
Juhl, AK1
Goldstein, A1
Ke, C1
Oxvig, C1
Duan, C1
Kong, F1
Lin, S1
Wang, Z2
Bhattacharya, R1
Mazumder, D1
Yan, X1
Ma, C1
Tang, Y2
Kong, X1
Lu, J1
Zhang, M1
Vital-Jacome, M1
Cazares-Granillo, M1
Carrillo-Reyes, J1
Buitron, G1
Jacob, SI1
Douair, I1
Maron, L1
Ménard, G1
Rusjan, P1
Sabioni, P1
Di Ciano, P1
Mansouri, E1
Boileau, I1
Laveillé, A1
Capet, M1
Duvauchelle, T1
Schwartz, JC1
Robert, P1
Le Foll, B1
Xia, Y1
Chen, S1
Luo, M1
Wu, J1
Cai, S1
He, Y2
Garbacz, P1
Misiak, M1
Jackowski, K1
Yuan, Q1
Sherrell, PC1
Chen, J2
Bi, X1
Nutho, B1
Mahalapbutr, P1
Hengphasatporn, K1
Pattaranggoon, NC1
Simanon, N1
Shigeta, Y1
Hannongbua, S1
Rungrotmongkol, T1
Caffrey, PJ1
Kher, R1
Bian, K1
Delaney, S1
Xue, J1
Wu, P1
Xu, L1
Yuan, Y1
Luo, J1
Ye, S1
Ustriyana, P1
Wei, B1
Raee, E1
Hu, Y1
Wesdemiotis, C1
Sahai, N1
Kaur, A1
Nigam, K1
Srivastava, S1
Tyagi, A1
Dang, S1
Millar, JE1
Bartnikowski, N1
Passmore, MR1
Obonyo, NG1
Malfertheiner, MV1
von Bahr, V1
Redd, MA1
See Hoe, L1
Ki, KK1
Pedersen, S1
Boyle, AJ1
Baillie, JK1
Shekar, K1
Palpant, N1
Suen, JY1
Matthay, MA1
McAuley, DF1
Fraser, JF1
Settles, JA1
Gerety, GF1
Spaepen, E1
Suico, JG1
Child, CJ1
Oh, BL1
Lee, JS1
Lee, EY1
Lee, HY1
Yu, HG1
Leslie, I1
Boos, LA1
Larkin, J1
Pickering, L1
Lima, HK1
Vogel, K1
Hampel, D1
Wagner-Gillespie, M1
Fogleman, AD1
Ferraz, SL1
O'Connor, M1
Mazzucchelli, TG1
Kajiyama, H1
Suzuki, S1
Shimbo, A1
Utsumi, F1
Yoshikawa, N1
Kikkawa, F1
Javvaji, PK1
Dhali, A1
Francis, JR1
Kolte, AP1
Roy, SC1
Selvaraju, S1
Mech, A1
Sejian, V1
DeSilva, S1
Vaidya, SS1
Mao, C1
Akhatayeva, Z1
Cheng, H1
Zhang, G1
Jiang, F1
Meng, X1
Elnour, IE1
Lan, X1
Song, E1
Rohde, S1
Antonides, CFJ1
Muslem, R1
de Woestijne, PCV1
der Meulen, MHV1
Kraemer, US1
Dalinghaus, M1
Bogers, AJJC1
Pourmand, A1
Ghassemi, M1
Sumon, K1
Amini, SB1
Hood, C1
Sikka, N1
Duan, H1
Chen, WP1
Fan, M1
Wang, WP1
Yu, L1
Tan, SJ1
Xin, S1
Wan, LJ1
Guo, YG1
Tanda, S1
Gingl, K1
Ličbinský, R1
Hegrová, J1
Goessler, W1
Li, ZL1
Zhou, YL1
Yan, W1
Luo, L1
Su, ZZ1
Fan, MZ1
Wang, SR1
Zhao, WG1
Xu, D1
Hassan, HM1
Jiang, Z1
Bachmann, KF1
Haenggi, M1
Jakob, SM1
Takala, J1
Gattinoni, L1
Berger, D1
Bentley, RF1
Vecchiarelli, E1
Banks, L1
Gonçalves, PEO1
Thomas, SG1
Goodman, JM1
Mather, K1
Boachie, R1
Anini, Y1
Panahi, S1
Anderson, GH1
Luhovyy, BL1
Nafie, MS1
Arafa, K1
Sedky, NK1
Alakhdar, AA1
Arafa, RK1
Fan, S1
Hu, H1
Liang, J1
Hu, BC1
Wen, Z1
Hu, D1
Liu, YY1
Chu, Q1
Wu, MC1
Lu, X1
Wang, D1
Hu, M1
Shen, H1
Yao, M1
Dahlgren, RA1
Vysloužil, J1
Kulich, P1
Zeman, T1
Vaculovič, T1
Tvrdoňová, M1
Mikuška, P1
Večeřa, Z1
Stráská, J1
Moravec, P1
Balcar, VJ1
Šerý, O1
Qiao, L1
Xiong, X1
Peng, X1
Zheng, J1
Duan, J1
Xiao, W1
Zhou, HY1
Sui, ZY1
Zhao, FL1
Sun, YN1
Wang, HY1
Han, BH1
Jintao, X1
Shasha, Y1
Jincai, W1
Chunyan, L1
Mengya, Y1
Yongli, S1
Rasoanirina, BNV1
Lassoued, MA1
Miladi, K1
Razafindrakoto, Z1
Chaâbane-Banaoues, R1
Ramanitrahasimbola, D1
Cornet, M1
Sfar, S1
Liang, C1
Xing, Q1
Yi, JL1
Zhang, YQ1
Li, CY1
Tang, SJ1
Gao, C1
Sun, X1
Peng, M1
Sun, XF1
Zhang, T1
Shi, JH1
Liao, CX1
Gao, WJ1
Sun, LL1
Gao, Y1
Cao, WH1
Lyu, J1
Yu, CQ1
Wang, SF1
Pang, ZC1
Cong, LM1
Dong, Z1
Wu, F1
Wu, XP1
Jiang, GH1
Wang, XJ1
Wang, BY1
Li, LM1
Pan, L1
Wan, SP1
Yi, HWL1
He, HJ1
Yong, ZP1
Shan, GL1
Weng, TT1
Yan, SQ1
Gao, GP1
Wei, C1
Tao, FB1
Shao, ZH1
Yao, T1
Dong, S1
Shi, S1
Feng, YL1
Zhang, YW1
Wang, SP1
Shi, AX1
Operario, D1
Zhang, ZH1
Zhu, XF1
Zaller, N1
Gao, P1
Sun, YH1
Zhang, HB1
Khoo, BZE1
Lim, RS1
See, YP1
Yeo, SC1
Skagerlind, MSE1
Stegmayr, BG1
Carroll, A1
Griffiths, L1
Mahadevan, V1
Dua, J1
Thachil, J1
Zhang, QC1
Bian, HM1
Grundström, G1
Christensson, A1
Alquist, M1
Nilsson, LG1
Segelmark, M1
Carney, EF1
Raimundo, M1
Crichton, S1
Lei, K1
Sanderson, B1
Smith, J1
Brooks, J1
Ng, J1
Lemmich Smith, J1
McKenzie, C2
Beale, R2
Dickie, H2
Ostermann, M2
Tovey, L1
Gangi, S1
Terblanche, M1
Treacher, D1
Soltysiak, J1
Warzywoda, A1
Kociński, B1
Ostalska-Nowicka, D1
Benedyk, A1
Silska-Dittmar, M1
Zachwieja, J1
Schilder, L1
Nurmohamed, SA1
Bosch, FH1
Purmer, IM1
den Boer, SS1
Kleppe, CG1
Vervloet, MG1
Beishuizen, A1
Girbes, AR1
Ter Wee, PM1
Groeneveld, AB1
Oudemans-van Straaten, HM1
Jacobs, R1
Honore, PM1
Spapen, HD1
Atalan, HK1
Gucyetmez, B1
Dumantepe, M1
Berktas, M1
Denizalti, TB1
Tarhan, İA1
Ozler, A1
Fajardo, C1
Sanchez, CP1
Cutler, D1
Sahney, S1
Sheth, R1
Wright, S1
Steinwandel, U1
Ferrari, P1
Chen, C1
Ye, C1
Weber, LL1
Dunbar, NM1
Dumont, LJ1
Szczepiorkowski, ZM1
Inoue, M1
Sasaki, M1
Katada, Y1
Fujiu, K1
Manabe, I1
Nagai, R1
Taguchi, T1
ENGELHARDT, H1
Buturović-Ponikvar, J1
Gubensek, J1
Ponikvar, R2
Chakroun, T1
Gerotziafas, GT1
Seghatchian, J1
Samama, MM1
Hatmi, M1
Elalamy, I1
Scully, M1
Longair, I1
Flynn, M1
Berryman, J1
Machin, SJ1
Macrae, JM1
Dojcinovic, I1
Djurdjev, O1
Jung, B1
Shalansky, S1
Levin, A1
Kiaii, M1
Yuasa, S1
Lockhart, MS1
Lee, ET1
Taylor, FB1
Buturović, J1
Kandus, A1
Boh, M1
Klinkmann, J1
Ivanovich, P1
Mehta, RL1
McDonald, BR1
Ward, DM1
Shibuya, N1
Fujishita, S1
de la Fuente, C1
Llorens, V1
Banzo, I1
Carril, JM1
Perdrix, JP1
Lepape, A1
Gronlier, T1
Grozel, JM1
Banssillon, V1
Rabaud, M1
Lefebvre, F1
Piquet, Y1
Belloc, F1
Chevaleyre, J1
Roudaut, MF1
Bricaud, H1
Rapaport, SI1
Zivelin, A1
Donnelly, K1

Clinical Trials (9)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Citrate Versus Heparin in Continuous Renal Replacement Therapy : Effect on Cardiovascular System and Clot Circuit in Critically Ill Patients[NCT04865510]41 participants (Actual)Interventional2019-02-04Completed
Prospective Randomized Multicenter Study to Demonstrate the Benefits of Hemodialysis Without Acetate (With Citrate): ABC-treat Study[NCT03319680]90 participants (Anticipated)Interventional2016-05-31Recruiting
The Use of Tetrasodium EDTA Catheter Lock Solution for Patients on Home Parenteral Nutrition: Ease of Use and Cost Analysis[NCT04067245]20 participants (Anticipated)Interventional2019-04-01Recruiting
Prospective, Randomized, Controlled Trial Evaluating the Efficacy of a Lock-therapy With a Solution of Taurolidine/Citrate (TauroLock) vs Standard Saline Solution for the Primary Prevention of Catheter-related Infections (CLI) in Adult Patients Wtih a Non[NCT02279121]162 participants (Actual)Interventional2014-11-30Completed
Bicarbonate vs Heparin Catheter Lock in Chronic Hemodialysis Patients[NCT04054128]Phase 460 participants (Actual)Interventional2019-09-11Active, not recruiting
Evaluation of the Efficacy of Prophylactic Topical Gentamicin in Tunnelled Catheters for Hemodialysis: a Randomized, Double-blind Clinical Trial[NCT04967859]Phase 190 participants (Actual)Interventional2018-07-01Completed
Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy During Veno-venous ECMO: a Crossover Randomized Controlled Study[NCT05148026]20 participants (Anticipated)Interventional2021-11-14Recruiting
Citrate Versus Heparin Anticoagulation in Continuous Venovenous Hemofiltration in Critically Ill Patients With Acute Renal Failure: A Randomized Clinical Trial[NCT00209378]139 participants (Actual)Interventional2005-05-31Completed
Citrate 4% Versus Heparinised Saline in Preventing Peripherally Inserted Central Catheter (PICC) Occlusions[NCT03114722]Phase 2130 participants (Anticipated)Interventional2017-07-31Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

3 reviews available for citric acid, anhydrous and Thrombosis

ArticleYear
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2014, Volume: 63, Issue:3

    Topics: Anticoagulants; Catheter-Related Infections; Central Venous Catheters; Citric Acid; Heparin; Humans;

2014
Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2014, Volume: 63, Issue:3

    Topics: Anticoagulants; Catheter-Related Infections; Central Venous Catheters; Citric Acid; Heparin; Humans;

2014
Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2014, Volume: 63, Issue:3

    Topics: Anticoagulants; Catheter-Related Infections; Central Venous Catheters; Citric Acid; Heparin; Humans;

2014
Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2014, Volume: 63, Issue:3

    Topics: Anticoagulants; Catheter-Related Infections; Central Venous Catheters; Citric Acid; Heparin; Humans;

2014
Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2014, Volume: 63, Issue:3

    Topics: Anticoagulants; Catheter-Related Infections; Central Venous Catheters; Citric Acid; Heparin; Humans;

2014
Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2014, Volume: 63, Issue:3

    Topics: Anticoagulants; Catheter-Related Infections; Central Venous Catheters; Citric Acid; Heparin; Humans;

2014
Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2014, Volume: 63, Issue:3

    Topics: Anticoagulants; Catheter-Related Infections; Central Venous Catheters; Citric Acid; Heparin; Humans;

2014
Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2014, Volume: 63, Issue:3

    Topics: Anticoagulants; Catheter-Related Infections; Central Venous Catheters; Citric Acid; Heparin; Humans;

2014
Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2014, Volume: 63, Issue:3

    Topics: Anticoagulants; Catheter-Related Infections; Central Venous Catheters; Citric Acid; Heparin; Humans;

2014
Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2014, Volume: 63, Issue:3

    Topics: Anticoagulants; Catheter-Related Infections; Central Venous Catheters; Citric Acid; Heparin; Humans;

2014
Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2014, Volume: 63, Issue:3

    Topics: Anticoagulants; Catheter-Related Infections; Central Venous Catheters; Citric Acid; Heparin; Humans;

2014
Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2014, Volume: 63, Issue:3

    Topics: Anticoagulants; Catheter-Related Infections; Central Venous Catheters; Citric Acid; Heparin; Humans;

2014
Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2014, Volume: 63, Issue:3

    Topics: Anticoagulants; Catheter-Related Infections; Central Venous Catheters; Citric Acid; Heparin; Humans;

2014
Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2014, Volume: 63, Issue:3

    Topics: Anticoagulants; Catheter-Related Infections; Central Venous Catheters; Citric Acid; Heparin; Humans;

2014
Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2014, Volume: 63, Issue:3

    Topics: Anticoagulants; Catheter-Related Infections; Central Venous Catheters; Citric Acid; Heparin; Humans;

2014
Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2014, Volume: 63, Issue:3

    Topics: Anticoagulants; Catheter-Related Infections; Central Venous Catheters; Citric Acid; Heparin; Humans;

2014
[Complications and adverse effects of plasmapheresis and their incidences].
    Nihon rinsho. Japanese journal of clinical medicine, 1984, Volume: 42, Issue:8

    Topics: Adolescent; Adult; Aged; Anticoagulants; Arrhythmias, Cardiac; Bacterial Infections; Citrates; Citri

1984

Trials

8 trials available for citric acid, anhydrous and Thrombosis

ArticleYear
The effect of citrate in cardiovascular system and clot circuit in critically ill patients requiring continuous renal replacement therapy.
    Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs, 2023, Volume: 26, Issue:1

    Topics: Acute Kidney Injury; Anticoagulants; Cardiovascular System; Citrates; Citric Acid; Continuous Renal

2023
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis.
    European journal of clinical pharmacology, 2018, Volume: 74, Issue:3

    Topics: Aged; Anticoagulants; Blood Coagulation; Case-Control Studies; Citric Acid; Drug Liberation; Female;

2018
Replacement of acetate with citrate in dialysis fluid: a randomized clinical trial of short term safety and fluid biocompatibility.
    BMC nephrology, 2013, Oct-09, Volume: 14

    Topics: Acetates; Acidosis; Biocompatible Materials; Citric Acid; Dialysis Solutions; Female; Humans; Male;

2013
Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.
    Critical care (London, England), 2014, Aug-16, Volume: 18, Issue:4

    Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anticoagulants; Citric Acid; Critical Illness;

2014
Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.
    Critical care (London, England), 2014, Aug-16, Volume: 18, Issue:4

    Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anticoagulants; Citric Acid; Critical Illness;

2014
Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.
    Critical care (London, England), 2014, Aug-16, Volume: 18, Issue:4

    Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anticoagulants; Citric Acid; Critical Illness;

2014
Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.
    Critical care (London, England), 2014, Aug-16, Volume: 18, Issue:4

    Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anticoagulants; Citric Acid; Critical Illness;

2014
Inpatient citrate-based hemodialysis in pediatric patients.
    Pediatric nephrology (Berlin, Germany), 2016, Volume: 31, Issue:10

    Topics: Adolescent; Anticoagulants; Catheters; Child; Child, Preschool; Citric Acid; Female; Hemodialysis So

2016
Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS).
    Clinical journal of the American Society of Nephrology : CJASN, 2008, Volume: 3, Issue:2

    Topics: Aged; Anticoagulants; Catheterization; Citric Acid; Feasibility Studies; Female; Heparin; Humans; Ma

2008
Filling hemodialysis catheters in the interdialytic period: heparin versus citrate versus polygeline: a prospective randomized study.
    Artificial organs, 1998, Volume: 22, Issue:11

    Topics: Aged; Anticoagulants; Catheterization, Central Venous; Citric Acid; Female; Heparin; Humans; Kidney

1998

Other Studies

30 other studies available for citric acid, anhydrous and Thrombosis

ArticleYear
Candidates for smart cardiovascular medical device coatings: A comparative study with endothelial and smooth muscle cells.
    European journal of pharmacology, 2021, Nov-05, Volume: 910

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line; Cell Proliferation; Cell Survival; Citri

2021
Blockage of citrate export prevents TCA cycle fragmentation via Irg1 inactivation.
    Cell reports, 2022, 02-15, Volume: 38, Issue:7

    Topics: Acetylation; Animals; Biological Transport; Carrier Proteins; Citric Acid; Citric Acid Cycle; Histon

2022
Citrate Phosphate Dextrose Alters Coagulation Dynamics Ex Vivo.
    The Journal of surgical research, 2023, Volume: 291

    Topics: Blood Coagulation; Blood Coagulation Tests; Citrates; Citric Acid; Glucose; Humans; Thrombelastograp

2023
Thromboelastography and Traditional Coagulation Testing in Non-ICU-Admitted Patients with Acute Kidney Injury: An Observational Cohort Study.
    American journal of nephrology, 2023, Volume: 54, Issue:5-6

    Topics: Acute Kidney Injury; Anticoagulants; Citric Acid; Cohort Studies; Fibrinogen; Heparin; Humans; Throm

2023
Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy - A Safe and Effective Low-Dose Protocol.
    Nephrology (Carlton, Vic.), 2020, Volume: 25, Issue:4

    Topics: Aged; Anticoagulants; Blood Coagulation; Citric Acid; Continuous Renal Replacement Therapy; Female;

2020
Dialysis circuit clotting in critically ill patients with COVID-19 infection.
    BMC nephrology, 2021, 04-20, Volume: 22, Issue:1

    Topics: Acute Kidney Injury; Aged; Anticoagulants; Case-Control Studies; Citric Acid; Cohort Studies; Contin

2021
Recurrent thrombosis despite a therapeutic international normalised ratio.
    Clinical medicine (London, England), 2013, Volume: 13, Issue:2

    Topics: Adult; Anticoagulants; Citric Acid; Fibrinolytic Agents; Fontan Procedure; Heart Defects, Congenital

2013
Anti-thrombotic effect of a novel formula from Corni fructus with malic acid, succinic acid and citric acid.
    Phytotherapy research : PTR, 2014, Volume: 28, Issue:5

    Topics: Animals; Citric Acid; Cornus; Malates; Male; Mice; Mice, Inbred ICR; Pulmonary Embolism; Rats; Rats,

2014
Dialysis: Efficacy of catheter lock solutions.
    Nature reviews. Nephrology, 2014, Volume: 10, Issue:1

    Topics: Catheter-Related Infections; Central Venous Catheters; Citric Acid; Heparin; Humans; Randomized Cont

2014
Maintaining normal levels of ionized calcium during citrate-based renal replacement therapy is associated with stable parathyroid hormone levels.
    Nephron. Clinical practice, 2013, Volume: 124, Issue:1-2

    Topics: Aged; Anticoagulants; Calcium; Citric Acid; Female; Humans; Ions; Kidney Failure, Chronic; Male; Par

2013
Beyond the randomized clinical trial: citrate for continuous renal replacement therapy in clinical practice.
    Nephron. Clinical practice, 2013, Volume: 124, Issue:1-2

    Topics: Aged; Anticoagulants; Chelating Agents; Citric Acid; Evidence-Based Medicine; Female; Humans; Male;

2013
Citrate anticoagulation for continuous renal replacement therapy in small children.
    Pediatric nephrology (Berlin, Germany), 2014, Volume: 29, Issue:3

    Topics: Acute Kidney Injury; Age Factors; Anticoagulants; Body Weight; Child, Preschool; Citric Acid; Critic

2014
Citrate for continuous renal replacement therapy: safer, better and cheaper.
    Critical care (London, England), 2014, Dec-03, Volume: 18, Issue:6

    Topics: Acute Kidney Injury; Citric Acid; Female; Hemofiltration; Heparin; Humans; Male; Thrombosis

2014
Some metabolic issues should not be neglected when using citrate for continuous renal replacement therapy!
    Critical care (London, England), 2015, Feb-06, Volume: 19

    Topics: Acute Kidney Injury; Citric Acid; Female; Hemofiltration; Heparin; Humans; Male; Thrombosis

2015
The combined use of pumpless extracorporeal lung assist and continuous arteriovenous hemofiltration with citrate anticoagulation in polytrauma patients.
    Intensive care medicine, 2015, Volume: 41, Issue:11

    Topics: Anticoagulants; Calcium Chelating Agents; Citric Acid; Extracorporeal Membrane Oxygenation; Hemofilt

2015
Citrate anticoagulation using ACD solution A during long-term haemodialysis.
    Nephrology (Carlton, Vic.), 2011, Volume: 16, Issue:4

    Topics: Aged; Analysis of Variance; Anticoagulants; Bicarbonates; Biomarkers; Blood Coagulation; Calcium; Ci

2011
Regional anticoagulation with citrate for maintenance haemodialysis in a patient with liver cirrhosis for 30 months.
    Nephrology (Carlton, Vic.), 2011, Volume: 16, Issue:8

    Topics: Anticoagulants; Blood Coagulation; Citric Acid; Glucose; Hemodialysis Solutions; Humans; Kidney Fail

2011
Successful use of citrate anticoagulant with heparin bolus for excessive clotting during extracorporeal photopheresis.
    Transfusion, 2012, Volume: 52, Issue:11

    Topics: Anticoagulants; Citric Acid; Drug Therapy, Combination; Graft vs Host Disease; Heparin; Humans; Male

2012
Poly-(L-lactic acid) and citric acid-crosslinked gelatin composite matrices as a drug-eluting stent coating material with endothelialization, antithrombogenic, and drug release properties.
    Journal of biomedical materials research. Part A, 2013, Volume: 101, Issue:7

    Topics: Animals; Benzoates; Cell Proliferation; Citric Acid; Compomers; Cross-Linking Reagents; Delayed-Acti

2013
[Demonstration of increased coagulability of citrated blood using Halse's recalcification test; and the significance of the said method in the treatment of thrombosis].
    Bruns' Beitrage zur klinischen Chirurgie, 1953, Volume: 187, Issue:4

    Topics: Blood Coagulation; Citric Acid; Coagulants; Humans; Prothrombin Time; Thrombosis

1953
Citrate anticoagulation for single-needle hemodialysis: safety and efficacy.
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2005, Volume: 9, Issue:3

    Topics: Aged; Anticoagulants; Calcium Chloride; Catheters, Indwelling; Citric Acid; Female; Hemodialysis Sol

2005
The influence of fibrin polymerization and platelet-mediated contractile forces on citrated whole blood thromboelastography profile.
    Thrombosis and haemostasis, 2006, Volume: 95, Issue:5

    Topics: Biomechanical Phenomena; Blood Coagulation; Blood Platelets; Citric Acid; Cytochalasin D; Dose-Respo

2006
Cryosupernatant and solvent detergent fresh-frozen plasma (Octaplas) usage at a single centre in acute thrombotic thrombocytopenic purpura.
    Vox sanguinis, 2007, Volume: 93, Issue:2

    Topics: Acute Disease; Citric Acid; Detergents; Humans; Hypersensitivity; Infections; Plasma; Plasma Exchang

2007
Observations on optimal conditions for lysis of whole blood clots and use of this assay as a screening assay in clinical investigation.
    Thrombosis research, 1982, Dec-01, Volume: 28, Issue:5

    Topics: Blood Platelet Disorders; Citrates; Citric Acid; Clot Retraction; Edetic Acid; Fibrin Fibrinogen Deg

1982
Regional citrate anticoagulation for continuous arteriovenous hemodialysis. An update after 12 months.
    Contributions to nephrology, 1991, Volume: 93

    Topics: Acute Kidney Injury; Citrates; Citric Acid; Evaluation Studies as Topic; Hemofiltration; Hemorrhage;

1991
[Complications with plasmapheresis].
    Nihon rinsho. Japanese journal of clinical medicine, 1991, Volume: 49 Suppl

    Topics: Albumins; Citrates; Citric Acid; Complement Activation; Embolism, Air; Hemolysis; Heparin; Humans; H

1991
Gallium-67 citrate scintigraphy in Salmonella infected thrombus of a left ventricular aneurysm.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1989, Volume: 30, Issue:7

    Topics: Citrates; Citric Acid; Gallium; Heart Aneurysm; Heart Diseases; Humans; Male; Middle Aged; Radionucl

1989
[Regional anticoagulation with citrate in hemodialysis in patients with a high risk for hemorrhage].
    Annales francaises d'anesthesie et de reanimation, 1988, Volume: 7, Issue:1

    Topics: Adult; Aged; Blood Coagulation; Calcium; Citrates; Citric Acid; Female; Hemorrhage; Humans; Male; Mi

1988
Soluble fibrinogen derivatives generated by thrombin: affinity for elastin.
    Thrombosis research, 1986, Jul-15, Volume: 43, Issue:2

    Topics: Animals; Arteriosclerosis; Calcium; Cattle; Citrates; Citric Acid; Dialysis; Elastin; Fibrinogen; Hu

1986
A plasma protein C activity assay suitable for a clinical laboratory. Its use to measure activity in hereditary and acquired deficiency states.
    American journal of clinical pathology, 1987, Volume: 87, Issue:4

    Topics: Antithrombin III; Citrates; Citric Acid; Humans; Liver Diseases; Partial Thromboplastin Time; Protei

1987